Evidence map›Paper›PMID 41377768›Full record

ArticleHealth science reports2025

Human Papillomavirus (HPV) and Infertility: A Cross-Sectional Study Exploring Its Prevalence and Effects in Iranian Couples.

Nasrin Aliabadi, Marzieh Hosseini, Sareh Doustfatemeh, Nahid Heydari Marandi, Marzie Joukar, Hossein Faramarzi, Naeimehossadat Asmarian, Niloofar Namazi

Abstract read
In one paragraph

Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nasrin AliabadiDepartment of Clinical Virology, Clinical Microbiology Research Center Shiraz University of Medical Sciences, Namazi Hospital Shiraz Iran.ORCID https://orcid.org/0000-0002-2202-4148
Marzieh HosseiniDepartment of Clinical Virology, Clinical Microbiology Research Center Shiraz University of Medical Sciences, Namazi Hospital Shiraz Iran.
Sareh DoustfatemehDepartment of Obstetrics and Gynecology, School of Medicine Shiraz University of Medical Sciences Shiraz Iran.
Nahid Heydari MarandiDepartment of Clinical Virology, Clinical Microbiology Research Center Shiraz University of Medical Sciences, Namazi Hospital Shiraz Iran.
Marzie JoukarInfertility Research Center Shiraz University of Medical Sciences Shiraz Iran.
Hossein FaramarziDepartment of Community Medicine, School of Medicine Shiraz University of Medical Sciences Shiraz Iran.
Naeimehossadat AsmarianAnesthesiology and Critical Care Research Center Shiraz University of Medical Sciences Shiraz Iran.
Niloofar NamaziDepartment of Obstetrics and Gynecology, School of Medicine Shiraz University of Medical Sciences Shiraz Iran.ORCID https://orcid.org/0000-0002-9993-6209

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Infertility, defined as the inability to conceive after 12 months of regular unprotected intercourse, affects approximately 16% of the global population and is a growing concern in Iran. This study aimed to evaluate the prevalence of high-risk human papillomavirus (HPV) genotypes in infertile couples and to investigate the association of HPV infection with infertility. Methods: This cross-sectional study examined the relationship between HPV and infertility in 354 participants (177 females, 177 males) from Hazrat Zainab Hospital's ART clinics in 2024. Participants were aged 20-45 years and diagnosed with primary or secondary infertility. Biological samples (semen, cervical swabs, and uterine aspirates) were tested using real-time PCR for HPV detection and genotyping. Demographic, clinical, and lifestyle data were collected via questionnaires. Results: Among female participants, 30 (16.9%) tested positive for HPV, with 3 (12.5%) harboring high-risk types. The prevalence in male participants was slightly higher, with 23 (13%) testing positive, including 8 (40%) with high-risk HPV types. Key findings included a slightly lower age at marriage in HPV-positive females (24.73 ± 6.10 years vs. 26.23 ± 6.41 years in HPV-negative females) and reduced utilization of assisted reproductive techniques (e.g., IVF and IUI) was observed in HPV-positive individuals. Interestingly, smoking was less frequent in HPV-positive males (52.2%) compared to HPV-negative males (65.6%). HPV-positive males exhibited higher rates of self-employment and partner change but no significant differences in semen parameters. Conclusion: Our findings align with previous studies reporting moderate HPV prevalence rates (15%-25%) in infertile populations globally, emphasizing the potential role of HPV in reproductive dysfunction. While HPV's impact on sperm quality and endometrial receptivity may contribute to infertility, further research is needed to clarify causal relationships. Vaccination and targeted screening strategies could mitigate HPV-related risks and improve reproductive outcomes.

Indexed as

high‐risk HPVHPV prevalencehuman papillomavirusinfertilityreproductive healthsexually transmitted infections (STIs)

Identifiers

PMID41377768
PMCPMC12685764

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.